Skip to main content
. 2015 Oct 7;24(12):2020–2032. doi: 10.1002/pro.2813

Table 1.

Endpoint Activity for Selected Peptides with KDAC8

Peptide sequence Activity (pmol min−1 µg−1) Source protein(s) Ref a
ac‐FR{K‐ac}RW‐am 19.5 ± 3.6 Arf‐GAP with dual PH domain‐containing protein 1 (ADAP1) 3
ac‐SL{K‐ac}FG‐am 12.1 ± 2.4 Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (SDHD) 3, 6
ac‐IS{K‐ac}FD‐am 6.9 ± 2.0 AT‐rich interactive domain‐containing protein 1A (ARID1A) 25
ac‐LT{K‐ac}SP‐am 5.9 ± 2.8 Non‐muscle caldesmon (CALD1) 5
ac‐FA{K‐ac}WR‐am 4.5 ± 2.1 Fructose‐bisphosphate aldolase A (ALDOA); Fructose‐bisphosphate aldolase C (ALDOC) 3, 6
ac‐PV{K‐ac}FI‐am 3.5 ± 0.7 Cysteine‐rich protein 2‐binding protein (CSRP2BP) 3, 6
ac‐YS{K‐ac}GF‐am 2.8 ± 1.4 Src substrate cortactin (SRC) 3, 6
ac‐YQ{K‐ac}WD‐am 2.5 ± 0.8 Structural maintenance of chromosomes protein 3 (SMC3) 3, 6
ac‐AR{K‐ac}ST‐am 2.2 ± 0.3 Histone H3.1t (HIST3H3); Histone H3.3 (H3F3A); Histone H3.1 (HIST1H3A) 3, 52
ac‐FS{K‐ac}AF‐am 2.2 ± 0.8 Nucleolar RNA helicase II (DDX21) 3, 5, 6
ac‐TG{K‐ac}TF‐am 1.6 ± 0.3 Actin‐related protein 2/3 complex subunit 2 (ARPC2) 3, 5
ac‐VI{K‐ac}GF‐am 1.3 ± 0.1 Transferrin receptor protein 1 (TFRC) 4
ac‐LA{K‐ac}HA‐am 0.9 ± 0.8 Histone H2B type 1‐K (HIST1H2BK) 3, 5, 6
ac‐LH{K‐ac}LL‐am 0.6 ± 0.5 Nuclear receptor co‐activator 3 (NCOA3); Nucleoprotein TPR (TPR) 3, 5, 6, 25
ac‐SD{K‐ac}TI‐am None detected Tubulin alpha‐3 chain (TUBA3A) 5
a

Reference source that the sequence is acetylated, which usually does not coincide with a report that the sequence is a substrate for KDAC8.